Arrier Biotech Private Limited

Arrier Biotech Private Limited - pharma in Ambala, Haryana, India. Directors, charges & compliance details.
CIN U24290HR2021PTC092271 Incorporated 18 January 2021 ROC Haryana HQ Ambala, Haryana, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹7.36 Cr
▲ 40% YoY
Net profit · FY 2025
₹31.86 Lakh
Net margin 4.3%
EBITDA · FY 2025
₹47.08 Lakh
EBITDA margin 6.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Satisfied charges
₹30 Lakh
No open charges
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings

About Arrier Biotech Private Limited

Data last updated:

Arrier Biotech Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 January 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24290HR2021PTC092271. Its GSTIN is 06AAUCA6585H1Z2 (Haryana).

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anuradha and Ranjan Dhingra.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at # 396 Sector – 9, Ambala, Haryana, India – 134003.

As per the financials filed for FY 2025, the company reported a revenue of ₹7.36 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹31.86 Lakh (net margin 4.3%) and EBITDA of ₹47.08 Lakh (EBITDA margin 6.4%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years.

As per MCA filings, the company has satisfied charges of ₹30 Lakh on record.

Arrier Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0005921).

Company details

CIN U24290HR2021PTC092271
Registration Number 092271
Incorporation Date 18 January 2021
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-HR-01-0005921

Recognitions & Rankings of Arrier Biotech

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-HR-01-0005921

Contact details

Arrier Biotech Private Limited's registered office is in Ambala, Haryana.

  • Registered Address
    # 396 Sector – 9, Ambala, Haryana, India – 134003
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Arrier Biotech Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Arrier Biotech is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Arrier Biotech Private Limited, buy the company report.

Financials of Arrier Biotech Private Limited

FY 2025 filings available

Arrier Biotech Private Limited reported revenue of ₹7.36 Cr (up 40% YoY) for FY 2025.

Revenue · FY 2025
₹7.36 Cr ▲ 40%
Net profit · FY 2025
₹31.86 Lakh margin 4.3%
EBITDA · FY 2025
₹47.08 Lakh margin 6.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▲ 145%
3 years · compounded
▲ 90%

Revenue has grown at a compounded annual rate (CAGR) of 38% over three years, including 40% growth in the latest year. EBITDA rose 145% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹47.08 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹31.86 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin6.4%
Net Profit Margin4.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Arrier Biotech Private Limited, buy the company report.

Board of directors of Arrier Biotech Private Limited

Arrier Biotech has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
AnuradhaDirector18 Jan 20215 Years 9 MonthsCurrent
Ranjan DhingraDirector18 Jan 20215 Years 9 MonthsCurrent

Peer comparison

Arrier Biotech Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Winnexa Health Sciences Private Limited₹7.38 Cr (FY 2025)115.0%Indore, Madhya Pradesh, India
Immugen Lifesciences Private Limited₹7.38 Cr (FY 2023)-25.0%Nagpur, Maharashtra, India
Navodaya Pharmaceuticals Private Limited₹7.38 Cr (FY 2024)-19.0%Noida, Uttar Pradesh, India
Arrier Biotech Private Limitedthis company₹7.36 Cr (FY 2025)₹31.86 Lakh4.3%40.0%Ambala, Haryana, India
Prime Time Logistics Technologies Private Limited₹7.33 Cr (FY 2025)29.0%Hyderabad, Telangana, India
Dey's Medico Pvt Ltd₹7.32 Cr (FY 2024)3.0%West Bengal, India
Oldmed Healthcare Private Limited₹7.32 Cr (FY 2024)50.0%Lucknow, Uttar Pradesh, India

To see the full peer comparison of Arrier Biotech Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹30 Lakh
Breakdown by lending institutions
Others₹0.30 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Oct 2023100866446Others₹30 LakhSatisfied

To see the full charge records of Arrier Biotech Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Arrier Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Arrier Biotech has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAUCA6585H1Z2HaryanaActive17 Feb 2021

To see the full GST registrations and return filing status of Arrier Biotech Private Limited, buy the company report.

Recent activity

Arrier Biotech Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Anuradha was appointed as Director on 18 Jan 2021.

AGM
Arrier Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Arrier Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Charges
A charge registered on 27 Oct 2023 via Charge ID 100866446 with Others was fully satisfied on 11 Nov 2024.
Charges
A charge with Others amounted to Rs. 30.00 Lakh with Charge ID 100866446 was registered on 27 Oct 2023.
Appointed
Anuradha was appointed as Director.
Appointed
Ranjan Dhingra was appointed as Director.
Incorporation
18 Jan 2021
Arrier Biotech Private Limited was registered on 18 Jan 2021 with Roc Haryana & aged 5 years 9 months as per MCA records.

Frequently asked questions

Arrier Biotech is an active private limited company based in Ambala, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 January 2021 (5+ years old) and is registered under CIN U24290HR2021PTC092271.

Arrier Biotech has 2 current directors:

The latest financial statements of Arrier Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Arrier Biotech is 06AAUCA6585H1Z2, registered in Haryana.

The CIN (Corporate Identification Number) of Arrier Biotech is U24290HR2021PTC092271. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Arrier Biotech was incorporated on 18 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Haryana.

The peers of Arrier Biotech by revenue are Winnexa Health Sciences Private Limited, Immugen Lifesciences Private Limited, Navodaya Pharmaceuticals Private Limited, Prime Time Logistics Technologies Private Limited, Dey's Medico Pvt Ltd and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Anuradha was appointed as Director on 18 Jan 2021. Ranjan Dhingra was appointed as Director on 18 Jan 2021.

Yes, Arrier Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-01-0005921).

The registered office of Arrier Biotech is at # 396 Sector – 9, Ambala, Haryana, India – 134003.

Arrier Biotech operates in the pharma industry, in the pharmaceutical retailers and distributors segment.